Epistaxis Market to Record Overwhelming Hike in Revenues by 2026

Epistaxis, also referred as nose bleeding, is a common clinical condition that results in loss of blood from the tissue lining of the nose. Epistaxis is usually classified as anterior or posterior epistaxis. Anterior epistaxis is defined as the bleeding from the anterior septum of the nose that is usually known as Kiesselbach plexus. Anterior epistaxis is also known as acute epistaxis and is the most commonly encountered form that can be cured through various medical treatments. On the other hand, posterior nosebleeds originating from the back of nasal package, near the throat are a relatively less common clinical condition and can prove to be serious as it may result in significantly large amount of blood loss. The posterior nosebleeds lead to massive blood loss and difficulty in breathing that may result in fatigue, paleness, and chest pain. However, most nosebleeds are rarely life threatening and are benign, self-limiting, spontaneous but recurrent. Epistaxis can be caused due to various factors such as lack of humidity in the atmosphere that results in the drying of mucosal tract, hypertension, and nasal tumors and also due to consumption of certain drugs, smoking, and alcohol. According to the World Health Organization, approximately 60% of people across the globe has faced nose bleeding at least once in their lives.

Download PDF Brochure of This Business Research Report@ https://www.coherentmarketinsights.com/insight/request-pdf/771

The global epistaxis market was valued at US$ 130.0 million in 2016 and is expected to witness a CAGR of 5.7% during the forecast period (2017 – 2025).

Market Dynamics

The recent past has witnessed a steady rise in incidence of heart-related disorders leading to hypertension and high blood pressure. Hypertension serves to be one of the major causes of epistaxis and the increase in its prevalence is expected to be one of the major factors responsible to drive the growth of the global epistaxis market. Moreover, increase in number of patients suffering from nasal tumors of benign and malignant types also contributes to the market growth. According to the American Cancer Society, around 2000 new cases related to nasal cavity and paranasal sinuses are registered every year in the U.S. The same article states that the sinuses that are highly responsible for epistaxis are much more prevalent in certain areas of the world that includes South Africa and Japan. On the other hand, the surgical procedures that are used commonly for the treatment of epistaxis, known as cauterization, results in a large number of side effects such as pain, swelling, and running nose. This is expected to hinder the market growth over the forecast period. However, this leads to open up a wide scope for the existing as well as new market players to come up with innovative treatment options with minimum or no side effects to establish a significant position in the market.

Market Taxonomy

The report segments the global epistaxis market on the basis of product type and geography. On the basis of product type, the global epistaxis market is segmented into Vasoconstrictors, Anesthetics, Antibiotic Ointments, and Cauterizing Agents. On the basis of geography, the market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Increasing prevalence of hypertension and change in environment are expected to drive the growth of global epistaxis market

Rising cases of cardiovascular disorders, mainly hypertensive diseases, which are highly susceptible to hemorrhage are the leading causes of epistaxis. According to the Medical Statistics of World Health Organization in 2015, there were approximately 289,000 cases of hypertension recorded among pregnant women. According to the American Pregnancy Organization, the circulatory system expands during pregnancy so as to accommodate the baby. The expansion leads to increase in creation and circulation of blood that may lead to problematic issues and frequent nosebleeds during pregnancy. Thus, the rising number of pregnant women suffering from hypertensive diseases is expected to boost the global epistaxis market. Additionally, rising awareness among public regarding the benefits of medical assistance for frequent bouts of bleeding also support the growth of global epistaxis market. Alongside, rise in the geriatric population, as well as rapid technological development in the healthcare sector, add up to the market growth. However, side effects of cauterization procedures such as chemical allergies and pain, swelling, bruises, and running nose may hinder the market growth.

Key players are involved in research and development for technological advancements and innovation of epistaxis products. For instance, in 2016, Smith & Nephew launched a range of epistaxis devices with RAPID RHINO technology that has a blend of carboxymethylcellulose (CMC) within them exhibiting self-lubricating properties that provide gentle and even compression to the nasal area and helps in the quicker re-conformation of the nasal anatomy. Various similar technological advancements and strategic implementations by emerging and established market players are expected to foster the global epistaxis market growth.

Request For Customization Of This Business Research Report@ https://www.coherentmarketinsights.com/insight/request-customization/771

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.